I'm sure they know about Guidance Note 08 ...Now, I'm a...

I'm sure they know about Guidance Note 08 ...


Now, I'm a reasonable person and I reckon it could have a material effect if they:
(a) didn't do the deal which they said was going to go ahead (especially since investors may have originally thought they would be supplying all 20,000 participants on Project Twenty21 with MC, on commercial terms, as they said in their 2019 announcement);
(b) failed to follow ASX listing rules.

So I'd like it to be clarified officially by Althea, since this is now a market rumour! If incorrect, it would be a matter for the ASX to review and take up with Bod Australia.

I'm also still confused about why the UK Pharma deal didn't get announced - perhaps all of this is because these things are happening through their UK wholly-owned subsidiary? But that still relates to them and impacts their share price, so a reasonable person would expect the information to be announced to the ASX.

Below are some parts of the Listing Rules document - or you can read the whole document here:
https://www.asx.com.au/documents/rules/gn08_continuous_disclosure.pdf

In 4.1 it gives examples of information which could be market sensitive:

Furthermore:


It continues:




I can vouch that I would like confirmation either way in order to decide how much to invest in Althea.

Here's a section relating to the earlier announcement, in case there has been a change (page 13):


Concerning timings, since Bod has already announced this information (assuming they have not made a mistake):


There's some good guidance on whether or not to put information on your website without providing it through ASX (e.g. their UK Pharma announcement):


Page 40 on cherry-picking good information:

Althea have been made aware of the announcement by Bod.
Regards,
Rob
DYOR - I'm trying to do mine